Merck & Co. has struck a $9.2 billion deal to buy biotechnology company Cidara Therapeutics in a move that bolsters the drugmaker’s respiratory portfolio.
Source link
About The Author
Merck to Buy Cidara Therapeutics in $9.2 Billion Deal